CRISPR Epigenome Editing Shows Promise for Treating Disease

Researchers are using CRISPR technology to edit the epigenome, which controls gene expression without changing the underlying DNA code. This method is being explored to treat diseases by switching genes on or off, potentially offering a new therapeutic avenue. The approach targets the regulatory layers of our genetic material, not the genes themselves.